The endocannabinoid system as a target for therapeutic drugs. (Q33934278)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10838609%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

title

The endocannabinoid system as a target for therapeutic drugs (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10838609%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

main subject

endocannabinoid system

0 references

author

Andrea Giuffrida

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10838609%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Antonio Calignano

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10838609%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

author name string

D Piomelli

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10838609%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

F Rodríguez de Fonseca

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10838609%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

publication date

1 June 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10838609%20AND%20SRC:MED&resulttype=core&format=json

Trends in Pharmacological Sciences

7 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10838609%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

volume

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10838609%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10838609%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

page(s)

218-224

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10838609%20AND%20SRC:MED&resulttype=core&format=json

publication type of scholarly work

7 November 2019

review article

1 reference

Structure of a cannabinoid receptor and functional expression of the cloned cDNA

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901482-6

7 January 2021

Isolation and structure of a brain constituent that binds to the cannabinoid receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901482-6

7 January 2021

2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901482-6

7 January 2021

Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901482-6

7 January 2021

Endogenous cannabinoid signaling

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901482-6

7 January 2021

Dopamine activation of endogenous cannabinoid signaling in dorsal striatum

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901482-6

7 January 2021

Functional Role of High-Affinity Anandamide Transport, as Revealed by Selective Inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901482-6

7 January 2021

Structural determinants for recognition and translocation by the anandamide transporter

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901482-6

7 January 2021

Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901482-6

7 January 2021

A second endogenous cannabinoid that modulates long-term potentiation

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901482-6

7 January 2021

Carbachol, an acetylcholine receptor agonist, enhances production in rat aorta of 2-arachidonoyl glycerol, a hypotensive endocannabinoid

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901482-6

7 January 2021

Enzymes of porcine brain hydrolyzing 2-arachidonoylglycerol, an endogenous ligand of cannabinoid receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901482-6

7 January 2021

Reversal of dopamine D(2) receptor responses by an anandamide transport inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901482-6

7 January 2021

Potentiation of anandamide hypotension by the transport inhibitor, AM404

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901482-6

7 January 2021

Extrapyramidal and neuroendocrine effects of AM404, an inhibitor of the carrier-mediated transport of anandamide

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901482-6

7 January 2021

Structure-activity relationships of anandamide, an endogenous cannabinoid ligand

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901482-6

7 January 2021

Molecular characterization of a peripheral receptor for cannabinoids

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901482-6

7 January 2021

Pharmacology of cannabinoid CB1 and CB2 receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901482-6

7 January 2021

Regulation of peripheral cannabinoid receptor CB2 phosphorylation by the inverse agonist SR 144528. Implications for receptor biological responses

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901482-6

7 January 2021

Cannabinoid receptors and immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901482-6

7 January 2021

Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901482-6

7 January 2021

Anandamide – the other side of the coin

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901482-6

7 January 2021

Are cannabinoids endogenous ligands for the VR1 capsaicin receptor?

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901482-6

7 January 2021

Anatomical basis for cannabinoid-induced antinociception as revealed by intracerebral microinjections

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901482-6

7 January 2021

Pre- and postsynaptic distribution of cannabinoid and mu opioid receptors in rat spinal cord

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901482-6

7 January 2021

Localization of central cannabinoid CB1 receptor messenger RNA in neuronal subpopulations of rat dorsal root ganglia: a double-label in situ hybridization study

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901482-6

7 January 2021

Hypoactivity of the Spinal Cannabinoid System Results in NMDA-Dependent Hyperalgesia

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901482-6

7 January 2021

Cannabinoid receptors undergo axonal flow in sensory nerves

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901482-6

7 January 2021

Control of pain initiation by endogenous cannabinoids.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901482-6

7 January 2021

Cannabinoids reduce hyperalgesia and inflammation via interaction with peripheral CB1 receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901482-6

7 January 2021

Cannabinoid transmission and pain perception

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901482-6

7 January 2021

Analgesic effect of the cannabinoid analogue nabilone is not mediated by opioid receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901482-6

7 January 2021

The analgesic effects of R(+)-WIN 55,212-2 mesylate, a high affinity cannabinoid agonist, in a rat model of neuropathic pain

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901482-6

7 January 2021

The cannabinoid receptor agonist WIN 55,212-2 mesylate blocks the development of hyperalgesia produced by capsaicin in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901482-6

7 January 2021

Spinal cannabinoids are anti-allodynic in rats with persistent inflammation.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901482-6

7 January 2021

Pain modulation by release of the endogenous cannabinoid anandamide

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901482-6

7 January 2021

The control of pain in peripheral tissue by opioids.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901482-6

7 January 2021

The action of synthetic cannabinoids on the induction of long-term potentiation in the rat hippocampal slice

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901482-6

7 January 2021

The changing landscape of ischaemic brain injury mechanisms.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901482-6

7 January 2021

Cannabinoid Receptor Agonists Protect Cultured Rat Hippocampal Neurons from Excitotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901482-6

7 January 2021

Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901482-6

7 January 2021

Adjuncts to dopamine replacement: a pragmatic approach to reducing the problem of dyskinesia in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901482-6

7 January 2021

CANNABIS AND SCHIZOPHRENIA A Longitudinal Study of Swedish Conscripts

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901482-6

7 January 2021

Chronic (-)-delta9-tetrahydrocannabinol treatment induces sensitization to the psychomotor effects of amphetamine in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901482-6

7 January 2021

Pharmacology of cannabinoid receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901482-6

7 January 2021

(R)-methanandamide: a chiral novel anandamide possessing higher potency and metabolic stability

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901482-6

7 January 2021

Agonist-inverse agonist characterization at CB1 and CB2 cannabinoid receptors of L759633, L759656, and AM630

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901482-6

7 January 2021

HU-308: a specific agonist for CB(2), a peripheral cannabinoid receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901482-6

7 January 2021

SR141716A, a potent and selective antagonist of the brain cannabinoid receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0165-6147%2800%2901482-6

7 January 2021